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Abstract 
Purpose: To obtain and evaluate carbopol hydrogel/sorbitan monostearate-almond oil-based organogel 
biphasic formulations (bigels) as a semi-solid vehicle for medicated topical applications.  
Methods: Bigel formulations were obtained under mild conditions at a hydrogel/organogel ratio of 
80/20, 70/30, and 60/40 (w/w). Their stability, viscosity, spreadability, microarchitecture, and acute skin 
toxicity were evaluated.  
Results: Two formulations, prepared at ratios of 80/20 and 70/30, were stable based on intermediate 
stability testing, and had a similar viscosity and spreadability (38.0 ± 1.0 mm and 37.3 ± 0.6 mm, p > 
0.05, respectively). Both of these formulations had a bimodal droplet size distribution and very similar 
values for the droplet mean diameter (0.33 ± 0.05 µm and 2.35 ± 0.44; and 0.34 ± 0.04 µm and 2.59 ± 
0.21 µm). The formulation obtained at a ratio of 60/40 was unstable during storage. The in vivo results 
did not reveal any signs of skin toxicity.  
Conclusion: Considering their beneficial properties, the developed bigels are a potential semi-solid 
vehicle for topical application and exhibit a moisturizing effect.       
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Bigels are innovative formulations that constitute 
two-phase structured systems obtained by 
mixing hydrogel and organogel. These systems 
can overcome the disadvantages of both types of 
gels, including the limited ability to cross 
lipophylic barriers of the skin for hydrogels and 
the low patient compliance for organogels due to 
their stickiness and oily residues [1]. They can 
also combine all advantages of both drug 
formulations: (i) the ability to accommodate both 
hydrophilic and lipophilic drugs; (ii) ensure topical 
or transdermal drug delivery; (iii) provide 
controlled drug delivery; and (iv) improve patient 
compliance [1,2]. Furthermore, Almeida et al [3] 
demonstrated that bigel formulations have an 
enhanced moisturizing effect. These properties 
make them very promising candidates for topical 
formulations.  
 
Olive  oil [2],  sesame  oil  [4,5],  sunflower oil [6],  
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soybean oil [1,7] and fish oil [8,9] are the most 
commonly used oils for bigel preparation. 
Oleogels prepared from these oils are combined 
with hydrogels of natural and synthetic polymers: 
guar gum [4], gelatine [1], sodium alginate, 
hydroxypropyl methylcellulose [8], and carbopol 
[5,9].  
 
Almond oil has several advantageous properties 
[10,11] and is commonly used in cosmetic 
products. Sorbitan monostearate (Span® 60, 
SMS, hydrophilic-lipophilic balance value 4.7) is 
a hydrophobic nonionic surfactant used in 
pharmaceutical formulations as a water-in-oil 
emulsifying agent. This compound gels several 
organic solvents, as well as a range of vegetable 
oils [4,5,12]. The aim of this study was to obtain 
and evaluate carbopol hydrogel/SMS-almond oil 
based organogel biphasic formulations (bigels) 
as a vehicle for semi-solid drug formulations with 






All materials used in the study including 
Carbopol® 940 (The Lubrizol Corporation, USA), 
propylene glycol (Sigma-Aldrich, USA), Span® 60 
(Sigma-Aldrich, USA), 95 % ethanol (v/v), 
almond oil, triethanolamine, and purified water 




The in vivo experiment was approved by the 
Bulgarian Food Safety Agency (permit no. 
88/09.01.2014) and Ethics Committee of the 
Medical University of Plovdiv, Bulgaria (approval 
no. 1/22.01.2015) [13]. The experiment was 
performed in compliance with the Basel 
Declaration [14] and ICLAS Ethical Guideline for 
Researchers [15]. 
 
Six male Wistar rats (weight of 180 – 400 g) were 
used and maintained under standard laboratory 
conditions (temperature 22 ± 1 °C, humidity 45 
%, and 12-h light-cycle). The rodents received 
food and water ad libitum [13]. 
 
Bigel preparation  
 
To prepare bigels, both phases (hydrophilic and 
lipophilic) were obtained separately. The 
hydrogel contained Carbopol® 940 1.0 % (w/w), 
propylene glycol 5.0 % (w/w) [16], ethanol 95 % 
(v/v) 10.0 % (w/w), and purified water 84.0 % 
(w/w). The organogel contained almond oil 85.0 
% (w/w) and Span® 60 15.0 % (w/w). Briefly, the 
preparation was prepared as follows: the 
weighted Carbopol® 940 was dispersed in the 
mixture of purified water, propylene glycol, and 
ethanol (25 °C, 400 rpm). A stable hydrogel was 
formed after adding triethanolamine (pH 5.5 – 
6.5). Span® 60 was dissolved in almond oil (60 
°C, 100 rpm). A bigel was obtained when the 
heated organogel was added to the hydrogel 
under continuous stirring (500 rpm) to obtain a 
homogeneous mixture and with cooling to 
ambient temperatures. Three bigel formulations 
were prepared in hydrogel/organogel ratios of 
80/20, 70/30, and 60/40 (w/w); these were 
named BG20, BG30, and BG40, respectively. 
 
The prepared bigels were inspected visually for 





An optical microscope (Leica DM2000 LED, 
Leica Microsystems, Germany) equipped with a 
camera (Leica DMC 2900) and software for 
image processing (Leica Application Suite, LAS) 
was used. Samples were observed at a 
magnification of 40x after staining with a solution 
of methylene blue (methylthioninium chloride) 1.5 
% (w/v). 
 
Stability study of the bigel formulations 
 
Intermediate stability studies of the three bigel 
formulations were prepared according to the ICH 
guidelines. Bigels were packed in tightly closed 
plastic containers and stored at 30 ± 2 °С/65 ± 5 
% RH for 6 months [17]. Their physical stability 
was evaluated through observation for any 
change in color, phase separation, or syneresis 
at regular time intervals [5,18]. To assess 
changes in their microarchitecture during 
storage, they were subjected to optical 
microscopy, as described above. 
 
Droplet size distribution 
 
Droplet size distribution analysis of the tested 
formulations was performed using a Nanotrac 
Wave apparatus (Microtrac, Inc., USA). Microtrac 
software automatically provided information on 
multi-modal distributions. The samples were 
prepared using an equal quantity of bigels (1 % 
w/w) in phosphate buffer at pH 5.5. They were 
subjected to ultrasonic impact for 10 min to 
obtain a homogeneous emulsion before 
measuring the droplet mean diameter. Samples 
with a volume of 3 mL were analyzed at 25.0 ± 
0.5 °C. The measurements were performed three 
times and the results were recorded as the mean 
± standard deviation (SD) [5]. 
 
Andonova et al 
Trop J Pharm Res, July 2017; 16(7): 1457  
 
Determination of pH  
 
The pH values of 1 % aqueous dispersion of the 
prepared bigels were measured using a pH 
meter (inoLab pH 720), which was calibrated with 
standard buffer solutions. The measurement was 
performed three times and the pH of every bigel 
formulation was recorded as the mean value ± 
SD. 
 
Determination of viscosity  
 
Determination of the viscosity of bigel 
formulations was performed using a Selecta 
STS-2011 viscometer (J. P. SELECTA, s. a., 
Spain) at 25.0 ± 0.5 °С. A spindle R6 was used 
at 1, 2, 3, 4, 5, 6, and 10 rpm. The results were 
plotted after triplicate measurements (mean ± 
SD).  
 
Determination of the spreadability of bigel 
formulations 
 
Spreadability of the bigel formulations was 
evaluated as follows: 1 ± 0.01 g of sample was 
pressed between two horizontal plates (20 x 20 
cm), where the upper plate weighed 125 ± 1 g. 
The study temperature was maintained at 25.0 ± 
0.5 °C and the bigels were evaluated 48 h after 
their preparation [19]. The spread diameter (ɸ) 
was measured after 1 min [19-21]. The 
measurements were performed three times and 




ATR-FTIR analysis was performed with a 
NicoletTM iS TM 10 FT-IR Spectrometer 
equipped with a Smart iTRTM attenuated total 
reflectance sampling (ZnSe crystal) accessory 
(Thermo Scientific, Thermo Fisher Scientific, Inc., 
USA). The spectra were recorded from 4000 to 
650 cm−1 using a DTGS detector. All spectra 
were corrected for CO2 using internal software. 
 
Acute skin toxicity testing  
 
Six rats (weight 250 – 400 g) were selected 
for the skin toxicity tests (n = 6). Animals 
were anesthetized with an intraperitoneal 
injection of ketamine (90 mg/kgbw) and 
xylazine (10 mg/kgbw). Fur on the back of 
the rats was shaved and two fields with an 
area of 1 cm2 were marked. The sites were 
chosen to be as close to the rat neck as 
possible to avoid ingestion through animal 
licking of the site after treatment. One field 
was left untreated and one milliliter of the 
tested formulation was rubbed gently on the 
skin at the other site. The animals were 
returned to their cages and observed for 
symptoms of local and systemic toxicity. Skin 
toxicity was evaluated on the 1st, 24th, and 
48th hour after application. The results were 
photographed and irritation scores were 





Statistical analysis was performed using a one-
way ANOVA with GraphPad InStat software 3.10 





Characteristics of bigel formulations  
 
The gel formation was confirmed based on the 
tube inversion test [5] (Figure 1). BG40 had a 
different structure and consistency from that of 
BG20 and BG30, possibly due to the greater 
amount of almond oil organogel and the 
technological conditions (temperature, stirring 
speed, stirring time, etc.) used in its preparation. 
All bigel formulations had a white color with a 
creamy appearance and a pleasant scent of 
almond oil. BG20 and BG30 were not greasy to 
the touch, unlike BG40, in which the oil droplets 





Figure 1: Bigel formulations obtained after 





Figure 2 presents optical micrographs of the 
three bigel formulations in terms of the mutual 
disposition of the phases. In BG20 and BG30 
(Figure 2a and b), the almond oil organogel is 
dispersed in the form of small gel droplets with 
regular or oval shapes into the carbopol 
hydrogel. The oval shape is due to spreading of 
the bigel formulation on the slide prior to 
microscopy analysis. Both micrographs show 
individual droplets with dimensions larger than 5  
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a)      b)        c)  




Figure 3: Three bigel formulations after 6 months of storage at 30 ± 2 °С and 65 % ± 5 % humidity 
 
a)         b)         c)  
 
Figure 4: Optical microscopy of bigels at 40x after 6 months of storage at 30 ± 2 °С and 65 % ± 5 %  humidity: a) 
BG20; b) BG30, c) BG40 (Leica DMC2900) 
 
µm. This microstructure of bigel formulations can 
provide more stability during storage. In contrast, 
BG40 is characterized by a non-uniform structure 
due to the presence of large quantities of poorly 
dispersed almond oil organogel, which is not 
homogeneously mixed with carbopol hydrogel.\ 
 
Stability study of the bigel formulations 
 
Figure 3 shows three bigel formulations after 6 
months of storage at 30 ± 2 °С/65 % ± 5 % RH 
[17]. No changes were observed in the physical 
stability of BG20 and BG30, as opposed to 
BG40, during the stability study. Initial changes 
regarding the phase separation of BG40 were 
observed early in the experiment after about 1 
month storage, after which syneresis occurred. 
 
Optical microscopy was performed on the three 
bigel formulations to examine changes in their 
microarchitecture during storage. Figure 4 
presents the optical micrographs of BG20, BG30, 
and BG40 at the end of the intermediate stability 
study. BG20 and BG30 are characterized by a 
homogeneous distribution without any areas of 
confluence of almond oil organogel or carbopol 
hydrogel. This microstructure plays a crucial role 
in the physical stability of both bigels (BG20 and 
BG30). Figure 4c shows the microstructure of 
BG40, which is characterized by a fragmented 
and inhomogeneous structure and large, clearly 
delineated vacuoles indicative of syneresis. Due 
to the physical instability of BG40, subsequent 
investigations were performed using only bigel 
formulations of BG20 and BG30.  
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Figure 5: Droplet size distribution of the bigel formulations: a) BG20 and b) BG30 
 
Droplet size distribution 
 
This analysis revealed a broad bimodal droplet 
size distribution for both BG20 and BG30 (Figure 
5). In formulation BG20, 90 % of droplets were 
larger than 0.257 ± 0.06 µm, and only 5% were 
larger than 3.29 ± 0.51 µm. Similar results were 
observed for BG30. The droplet size ranged from 
0.244 ± 0.04 to 4.06 ± 0.62 µm. Table 1 shows 
the peak summary for the bimodal droplet size 
distribution of the tested formulations. The results 
indicated that the droplet mean diameter (the 50 
% point of each mode reported) was similar in 
both formulations. A difference in the volume % 
(the calculated contribution in percent of each 
peak to the total volume of the distribution) and 
width (a measure of the broadness of the peak 
under consideration) was established. 
Furthermore, the droplet mean diameter 
established for BG20 and BG30 was in 
agreement with the results of the optical 
microscopy analysis, as presented above. 
 
pH of bigel formulations 
 
The pH values of the bigel formulations were 
5.66 ± 0.03 and 6.33 ± 0.02 for BG20 and BG30, 
respectively. These values, which are within the 
range of the physiological pH of healthy skin, are 
important for physiological tolerance and a 
possible lack of skin irritation in topical 
applications [24]. 
 
Viscosity of bigel formulations 
 
Figure 6 shows the effect of shearing on the 
viscosity of bigels BG20 and BG30. Both bigel 
formulations exhibited pseudoplastic flow. A 
lower viscosity of BG20 was established 
compared to the viscosity of BG30 at all shearing 
values. An increase in shearing rate led to a 
decreased difference between the viscosities of 
both bigels. For example, the viscosities of bigel 
formulations were ~ 524.7 ± 66 Pa.s and 613.5 ± 
52 Pa.s for BG20 and BG30 at 1 rpm; 122.7 ± 17 
Pa.s and 150.7 ± 12 Pa.s for BG20 and BG30 at 
5 rpm; and 67.1 ± 9 Pa.s and 84.1 ± 5 Pa.s for 
BG20 and BG30, respectively, at 10 rpm. 
Statistical processing of the results suggest that 
the difference is not statistically significant (p > 
0.05). The higher viscosity of BG30 compared to 
BG20 can be explained by the higher SMS 
content in BG30. These results confirm the 
findings established by Ibrachim et al [7]. 
 
Determination of the spreadability of bigel 
formulations 
 
Spreadability is an important characteristic of 
semi-solid dosage forms: it determines 
extrudability from the package, the method of 
application (easy or difficult), accurate dosing, 
and patient preference. In this study, the 
spreadability of bigel formulations was 
determined by measuring the spread diameter 
(ɸ). 
 
Table 1: Peaks of bimodal droplet size distribution of formulations for BG20 and BG30 (n = 3) 
 










Peak 1 2.35±0.44 64.2±7.3 1.15±0.50 2.59±0.21 53.4±5.5 1.76±0.34 
Peak 2 0.33±0.05 35.8±7.3 0.30±0.06 0.34±0.04 46.6±5.5 0.29±0.07 
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Figure 6: Effect of shearing on the viscosity of bigel formulations BG20 and BG30. Note: …… = BG20; _____ = 
BG30 
 
The diameters of resulting circles (ɸ) were 38.0 ± 
1.0 mm and 37.3 ± 0.6 mm for BG20 and BG30, 
respectively. In a study on various oil-in-water 
creams and gels, Arvouet-Grand et al [20] and 
later Lardy et al [21] introduce the terms ‘semi-
stiff’ and ‘semi-fluid’ to evaluate the spreadability 
of creams and gels. According to both 
classifications, BG20 and BG30 are semi-stiff 
formulations, because the established (ɸ) was ≤ 
50 mm. Based on these results, the difference 
between the hydrogel/organogel ratio in both 
bigel formulations affects the spreadability of 




ATR-FTIR analysis was used to test for any 
chemical or physical interactions between the 
two phases: almond oil organogel and carbopol 
hydrogel. Figure 7 presents the spectra of bigel 
formulations (BG20 and BG30) and those of both 
gels before mixing (almond oil organogel and 
carbopol hydrogel). 
 
Almond oil organogel consists of almond oil and 
SMS. Its characteristic absorption peaks  in the 
range 2850 – 3000 cm-1, which is associated with 
the (–CH2–) group, which is strong and present 
in the spectra of both SMS [25] and almond oil 
[26]; the narrow peak located at 1744.51 cm-1 is 
associated with the (=C=O) group [27] and the 
peak at 1466.21 cm-1 belongs to the (–CH2–) 
group related to the (–CH3–) group [27]. In the 
spectra of both bigel formulations, the peaks at 
2921.29 and 2851.58 cm-1 were slightly shifted to 
2917.86 and 2850.03 and 2917.72 cm-1 and 
2850.16 cm-1 for BG20 and BG30, respectively. 
They were characterized based on the low 
intensity, which increased with increasing 
amounts of almond organogel. The same 
tendency was observed in terms of the peak 
localized at 1744.51 cm-1 in both spectra of 
BG20 and BG30.  
 
The carbopol hydrogel consists of Carbopol® 
940, propylene glycol, ethanol, purified water, 
and triethanolamine. This composition is 
responsible for the following characteristic peaks 
in the carbopol hydrogel spectrum: the peak 
located at 3362.03 cm-1 is associated with free (–
OH) groups; the carbonyl (=C=O) group can be 
determined between 1670 and 1820 cm-1, but 
conjugation shifts absorptions to lower wave 
numbers (the peak at 1644.75 cm-1); and peaks 
located at 1044.88 cm-1 indicate stretching 
vibration of the ethereal C–O–C group [27,28]. 
All three peaks are clearly visible in the spectra 
of bigel formulations of BG20 and BG30. 
 
These results are suggestive of a lack of 
chemical interaction between the almond oil 
organogel and carbopol hydrogel, as well as the 
existence of a physical mixture of the two phases 
[5]. 
 
Acute skin toxicity  
 
The acute skin toxicity test was conducted on six 
rats with BG30 to reduce the number of 
experimental animals used and because SMS is 
present in the bigel. No symptoms of skin toxicity 
(redness, edema), irritation, or inflammation were 
observed for the first 48 h after treatment. These 
results indicate that the tested BG30 formulation 
can be considered safe for dermal use. Our 
results are consistent with those of Rehman et al 
[29], who found that bigel formulations did not 
cause sensitization and may reduce imiquimod 
(a chemotherapeutic agent) inflammation. 
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Figure 7: ATR-FTIR spectra of both bigel formulations BG20 and BG30 compared with the spectra of almond oil 




Three bigel formulations with different carbopol 
hydrogel/almond oil organogel ratios were 
developed in the current study. Two formulations, 
BG20 and BG30, prepared at ratios of 80/20 and 
70/30, were stable according to the intermediate 
stability testing, and they had similar viscosity 
and spreadability. We observed a bimodal 
droplet size distribution and similar values for the 
droplet mean diameter. 
 
Regardless of the broad droplet distribution 
determined for both bigels, stability was 
maintained. This may be because most droplets 
were in the nanometer size range. These results 
were confirmed based on optical microscopy 
analysis, as discussed above. Furthermore, 
BG20 and BG30 constitute a physical mixture of 
carbopol hydrogel and almond oil organogel 
(which improves skin tolerance), which was 
confirmed based on acute skin toxicity testing 
and in accordance with the pH of the 
formulations. If a chemical interaction between 
the components of the bigels was observed, it 
would have been a prerequisite for skin 
sensitivity and for a change in the physical and 
mechanical characteristics of the system, which 
would affect stability and behavior as a drug 
delivery system. Both bigel formulations have 
similar characteristics; they may be used as drug 
delivery systems for hydrophilic and hydrophobic 
drugs, and selection of the bigel will depend on 
the targeted biopharmaceutical characteristics. 
 
Formulation BG40, which contains 40 % (w/w) 
almond oil organogel, is of particular interest. 
This system is very unstable and the first signs of 
physical instability were observed early. 
Syneresis was observed in the almond oil 
organogel as part of the bigel composition. The 
syneresis in BG40 can be explained by the 
imbalanced interfacial tension between almond 
oil, SMS, and the gravitational force [30].  
 
In contrast to the results of our study, Singh et al 
[4] found that bigels with a higher proportion of 
organogel remained stable at high temperatures 
and maintained their structural organization. 
According to the authors, the long alkyl 
hydrocarbon chain of SMS may be the stabilizing 
factor in this formulation.   
 
Molecules of the gelator tend to self-assemble 
via nucleation, when the organogelator-solvent 
melt is supersaturated (e.g., the temperature is 
below the melting point of the organogelator; 53 
°C for SMS). The growth is preferentially one-
dimensional, which leads to the formation of 
fibers. The degree of supersaturation is the 
primary factor influencing nucleation and growth. 
The stable state of organogels depends on: (i) 
hydrogen bonding; (ii) van der Waals forces as 
transient forces; (iii) and the mechanism of fiber 
growth, which is influenced by the nature of the 
liquid portion of the gel [30]. The presence of 
almond oil used in the current study may explain 
the difference in the physical stability of BG40 
and the bigel obtained by Singh et al [4], along 
with some technological differences in the 
preparation and storage of bigels. Rogers et al 
[30] found that differences in the physico-
mechanical characteristics of the examined 
organogels can be explained by the fiber growth 
model, as well as the storage temperature. 
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However, further studies are required to explore 




An effective method for the development of novel 
carbopol hydrogel/sorbitan monostearate-almond 
oil based bigels has been developed. The bigel 
formulations obtained at hydrogel/organogel 
ratios of 80/20 and 70/30 (w/w) are characterized 
by a homogeneous microstructure, viscosity and 
spreadability that are appropriate for semi-solid 
formulations. The formulations did not show any 
signs of skin toxicity. Thus, the developed bigels 
appear to be suitable semi-solid vehicles for 
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